Judy D. Olian United Therapeutics Corp (UTHR) insider trading activity

Judy D. Olian is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 5,655 shares of UTHR, which is worth approximately $2.03 Million. The most recent transaction as insider was on Nov 11, 2024, when has been sold 1,750 shares (Common Stock) at a price of $412.48 per share, resulting in proceeds of $721,840. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.66K

23.63% 3M change

22.59% 12M change

Total Value Held $2.03 Million

Judy D. Olian Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 11 2024	SELL Open market or private sale	$721,840 $412.48 p/Share	1,750 Reduced 23.63%	5,655 Common Stock
Sep 17 2024	SELL Exercise of conversion of derivative security	$812,406 $353.22 p/Share	2,300 Reduced 23.7%	7,405 Common Stock
Sep 17 2024	BUY Exercise of conversion of derivative security	$257,922 $112.14 p/Share	2,300 Added 19.16%	9,705 Common Stock
Jul 13 2024	BUY Exercise of conversion of derivative security	-	1,800 Added 19.55%	7,405 Common Stock
Jun 17 2024	SELL Open market or private sale	$502,231 $295.43 p/Share	1,700 Reduced 23.27%	5,605 Common Stock
May 03 2024	SELL Open market or private sale	$2,587,799 $258.78 p/Share	10,000 Reduced 57.79%	7,305 Common Stock
May 03 2024	BUY Exercise of conversion of derivative security	$1,754,300 $175.43 p/Share	10,000 Added 36.62%	17,305 Common Stock
Mar 12 2024	SELL Open market or private sale	$1,240,150 $248.03 p/Share	5,000 Reduced 40.63%	7,305 Common Stock
Mar 12 2024	BUY Exercise of conversion of derivative security	$877,150 $175.43 p/Share	5,000 Added 28.89%	12,305 Common Stock
Nov 29 2023	SELL Bona fide gift	-	950 Reduced 11.51%	7,305 Common Stock
Jul 07 2023	BUY Exercise of conversion of derivative security	-	1,750 Added 17.49%	8,255 Common Stock
Jan 03 2023	SELL Open market or private sale	$317,699 $276.26 p/Share	1,150 Reduced 15.02%	6,505 Common Stock
Dec 09 2022	SELL Open market or private sale	$284,820 $282.0 p/Share	1,010 Reduced 11.66%	7,655 Common Stock
Nov 08 2022	SELL Open market or private sale	$159,053 $265.09 p/Share	600 Reduced 6.48%	8,665 Common Stock
Nov 07 2022	SELL Bona fide gift	-	1,125 Reduced 10.83%	9,265 Common Stock
Jul 08 2022	BUY Exercise of conversion of derivative security	-	2,160 Added 17.21%	10,390 Common Stock
Jun 27 2022	SELL Open market or private sale	$2,406,400 $240.64 p/Share	10,000 Reduced 54.85%	8,230 Common Stock
Jun 27 2022	BUY Exercise of conversion of derivative security	$1,754,300 $175.43 p/Share	10,000 Added 35.42%	18,230 Common Stock
May 26 2022	SELL Open market or private sale	$2,264,600 $226.46 p/Share	10,000 Reduced 54.85%	8,230 Common Stock
May 26 2022	BUY Exercise of conversion of derivative security	$1,754,300 $175.43 p/Share	10,000 Added 35.42%	18,230 Common Stock
Nov 23 2021	SELL Bona fide gift	-	920 Reduced 10.05%	8,230 Common Stock
Jun 26 2021	BUY Exercise of conversion of derivative security	-	3,360 Added 26.86%	9,150 Common Stock
Apr 01 2021	SELL Open market or private sale	$778,127 $184.96 p/Share	4,207 Reduced 42.08%	5,790 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$321,247 $76.36 p/Share	4,207 Added 29.62%	9,997 Common Stock
Mar 17 2021	SELL Open market or private sale	$357,510 $170.0 p/Share	2,103 Reduced 26.64%	5,790 Common Stock

Also insider at

ARES

Ares Management Corp Financial Services

Director

MAT

MATTEL INC Consumer Cyclical

Director

JDO

Judy D. Olian

Los Angeles, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account